微电流疗法作为对抗阿尔茨海默氏症疾病的非药物新协议
Eun Ho Kim1, Won Seok Lee1, Jae Hee Lee2
1Department of Biochemistry, School of Medicine, Daegu Catholic University, Daegu, Republic of Korea.
Frontiers in aging neuroscience
|February 2, 2024
概括
微电流疗法通过改善记忆力和减少神经炎症,对阿尔茨海默氏症 (AD) 有希望. 这种非药理学方法为认知衰退提供了潜在的新治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 生物医学工程 生物医学工程
背景情况:
- 阿尔茨海默病 (AD) 是一个日益严重的全球健康问题,其特点是认知能力下降和神经炎症.
- 目前用于AD的药物治疗具有风险;需要进行非药物干预.
- 使用低电流的微电流治疗作为一种新的治疗方式被探索.
研究的目的:
- 研究微电流治疗作为阿尔茨海默病临床方案的疗效.
- 在AD小鼠模型中评估微电流治疗对认知功能和神经炎症的影响.
主要方法:
- 利用老鼠痴呆症模型来评估微电流治疗.
- 进行行为评估,包括新型物体识别测试 (NOR) 和辐射臂迷宫测试 (RAM).
- 通过测量Iba1和GFAP等关键蛋白质的表达来评估神经炎症.
主要成果:
- 在AD小鼠模型中,微电流治疗显著改善了记忆障碍.
- 在接受治疗的小鼠中观察到神经炎症标志物 (Iba1,GFAP) 的减少.
- 有证据表明,微电流疗法可以通过MAPK信号通路调节神经炎症.
结论:
- 微电流疗法为阿尔茨海默病提供了一种安全有效的非药物治疗策略.
- 这些发现支持开发一种新的AD治疗和神经恢复的临床方案.
- 对微电流刺激等非传统疗法的进一步研究对于复杂的神经疾病至关重要.
相关概念视频
01:22Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193
01:26Alzheimer's Disease: Overview
487
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
487